[1]
B. Yang and J. Luzum, “Pharmacogenetic Considerations in Beta-Blocker Therapy”, SMART-MD J. Precision Med., vol. 1, no. 2, pp. e9 - e13, Sep. 2024, doi: 10.69734/hpaezm84.